Global Peptide Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Peptide Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Peptide Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Peptide Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Peptide Vaccine Segment by Type

2.2.1 Solution Phase Synthesis (SPS)

2.2.2 Solid Phase Peptide Synthesis (SPPS)

2.3 Peptide Vaccine Sales by Type

2.3.1 Global Peptide Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Peptide Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Peptide Vaccine Sale Price by Type (2017-2022)

2.4 Peptide Vaccine Segment by Application

2.4.1 Prostate Cancer

2.4.2 Breast Cancer

2.4.3 Gastric Cancer

2.4.4 Lung Cancer

2.4.5 Pancreatic Cancer

2.4.6 Others

2.5 Peptide Vaccine Sales by Application

2.5.1 Global Peptide Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Peptide Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Peptide Vaccine Sale Price by Application (2017-2022)

3 Global Peptide Vaccine by Company

3.1 Global Peptide Vaccine Breakdown Data by Company

3.1.1 Global Peptide Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Peptide Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Peptide Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Peptide Vaccine Revenue by Company (2020-2022)

3.2.2 Global Peptide Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Peptide Vaccine Sale Price by Company

3.4 Key Manufacturers Peptide Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Peptide Vaccine Product Location Distribution

3.4.2 Players Peptide Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Peptide Vaccine by Geographic Region

4.1 World Historic Peptide Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Peptide Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Peptide Vaccine Annual Revenue by Geographic Region

4.2 World Historic Peptide Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Peptide Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Peptide Vaccine Annual Revenue by Country/Region

4.3 Americas Peptide Vaccine Sales Growth

4.4 APAC Peptide Vaccine Sales Growth

4.5 Europe Peptide Vaccine Sales Growth

4.6 Middle East & Africa Peptide Vaccine Sales Growth

5 Americas

5.1 Americas Peptide Vaccine Sales by Country

5.1.1 Americas Peptide Vaccine Sales by Country (2017-2022)

5.1.2 Americas Peptide Vaccine Revenue by Country (2017-2022)

5.2 Americas Peptide Vaccine Sales by Type

5.3 Americas Peptide Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Peptide Vaccine Sales by Region

6.1.1 APAC Peptide Vaccine Sales by Region (2017-2022)

6.1.2 APAC Peptide Vaccine Revenue by Region (2017-2022)

6.2 APAC Peptide Vaccine Sales by Type

6.3 APAC Peptide Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Peptide Vaccine by Country

7.1.1 Europe Peptide Vaccine Sales by Country (2017-2022)

7.1.2 Europe Peptide Vaccine Revenue by Country (2017-2022)

7.2 Europe Peptide Vaccine Sales by Type

7.3 Europe Peptide Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Peptide Vaccine by Country

8.1.1 Middle East & Africa Peptide Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Peptide Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Peptide Vaccine Sales by Type

8.3 Middle East & Africa Peptide Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Peptide Vaccine

10.3 Manufacturing Process Analysis of Peptide Vaccine

10.4 Industry Chain Structure of Peptide Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Peptide Vaccine Distributors

11.3 Peptide Vaccine Customer

12 World Forecast Review for Peptide Vaccine by Geographic Region

12.1 Global Peptide Vaccine Market Size Forecast by Region

12.1.1 Global Peptide Vaccine Forecast by Region (2023-2028)

12.1.2 Global Peptide Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Peptide Vaccine Forecast by Type

12.7 Global Peptide Vaccine Forecast by Application

13 Key Players Analysis

13.1 Anergis

13.1.1 Anergis Company Information

13.1.2 Anergis Peptide Vaccine Product Offered

13.1.3 Anergis Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Anergis Main Business Overview

13.1.5 Anergis Latest Developments

13.2 Antigen Express

13.2.1 Antigen Express Company Information

13.2.2 Antigen Express Peptide Vaccine Product Offered

13.2.3 Antigen Express Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Antigen Express Main Business Overview

13.2.5 Antigen Express Latest Developments

13.3 Apitope Technology

13.3.1 Apitope Technology Company Information

13.3.2 Apitope Technology Peptide Vaccine Product Offered

13.3.3 Apitope Technology Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Apitope Technology Main Business Overview

13.3.5 Apitope Technology Latest Developments

13.4 Artificial Cell Technologies

13.4.1 Artificial Cell Technologies Company Information

13.4.2 Artificial Cell Technologies Peptide Vaccine Product Offered

13.4.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Artificial Cell Technologies Main Business Overview

13.4.5 Artificial Cell Technologies Latest Developments

13.5 Benovus Bio

13.5.1 Benovus Bio Company Information

13.5.2 Benovus Bio Peptide Vaccine Product Offered

13.5.3 Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Benovus Bio Main Business Overview

13.5.5 Benovus Bio Latest Developments

13.6 Celgene Corporation

13.6.1 Celgene Corporation Company Information

13.6.2 Celgene Corporation Peptide Vaccine Product Offered

13.6.3 Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Celgene Corporation Main Business Overview

13.6.5 Celgene Corporation Latest Developments

13.7 Immatics biotechnologies

13.7.1 Immatics biotechnologies Company Information

13.7.2 Immatics biotechnologies Peptide Vaccine Product Offered

13.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Immatics biotechnologies Main Business Overview

13.7.5 Immatics biotechnologies Latest Developments

13.8 Merck

13.8.1 Merck Company Information

13.8.2 Merck Peptide Vaccine Product Offered

13.8.3 Merck Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merck Main Business Overview

13.8.5 Merck Latest Developments

13.9 ImmunoCellular Therapeutics

13.9.1 ImmunoCellular Therapeutics Company Information

13.9.2 ImmunoCellular Therapeutics Peptide Vaccine Product Offered

13.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ImmunoCellular Therapeutics Main Business Overview

13.9.5 ImmunoCellular Therapeutics Latest Developments

13.10 ISA Pharmaceuticals

13.10.1 ISA Pharmaceuticals Company Information

13.10.2 ISA Pharmaceuticals Peptide Vaccine Product Offered

13.10.3 ISA Pharmaceuticals Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 ISA Pharmaceuticals Main Business Overview

13.10.5 ISA Pharmaceuticals Latest Developments

13.11 Lytix Biopharma

13.11.1 Lytix Biopharma Company Information

13.11.2 Lytix Biopharma Peptide Vaccine Product Offered

13.11.3 Lytix Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Lytix Biopharma Main Business Overview

13.11.5 Lytix Biopharma Latest Developments

13.12 Spotlight Innovation

13.12.1 Spotlight Innovation Company Information

13.12.2 Spotlight Innovation Peptide Vaccine Product Offered

13.12.3 Spotlight Innovation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Spotlight Innovation Main Business Overview

13.12.5 Spotlight Innovation Latest Developments

13.13 OncoTherapy Science

13.13.1 OncoTherapy Science Company Information

13.13.2 OncoTherapy Science Peptide Vaccine Product Offered

13.13.3 OncoTherapy Science Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 OncoTherapy Science Main Business Overview

13.13.5 OncoTherapy Science Latest Developments

13.14 Peptech

13.14.1 Peptech Company Information

13.14.2 Peptech Peptide Vaccine Product Offered

13.14.3 Peptech Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Peptech Main Business Overview

13.14.5 Peptech Latest Developments

13.15 Pharmasyntez

13.15.1 Pharmasyntez Company Information

13.15.2 Pharmasyntez Peptide Vaccine Product Offered

13.15.3 Pharmasyntez Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Pharmasyntez Main Business Overview

13.15.5 Pharmasyntez Latest Developments

13.16 Sumitomo Dainippon Pharma

13.16.1 Sumitomo Dainippon Pharma Company Information

13.16.2 Sumitomo Dainippon Pharma Peptide Vaccine Product Offered

13.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Sumitomo Dainippon Pharma Main Business Overview

13.16.5 Sumitomo Dainippon Pharma Latest Developments

13.17 TapImmune

13.17.1 TapImmune Company Information

13.17.2 TapImmune Peptide Vaccine Product Offered

13.17.3 TapImmune Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 TapImmune Main Business Overview

13.17.5 TapImmune Latest Developments

13.18 Targovax

13.18.1 Targovax Company Information

13.18.2 Targovax Peptide Vaccine Product Offered

13.18.3 Targovax Peptide Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Targovax Main Business Overview

13.18.5 Targovax Latest Developments

14 Research Findings and Conclusion

Table 1. Peptide Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Peptide Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Solution Phase Synthesis (SPS)

Table 4. Major Players of Solid Phase Peptide Synthesis (SPPS)

Table 5. Global Peptide Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Peptide Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Peptide Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Peptide Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Peptide Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Peptide Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Peptide Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Peptide Vaccine Revenue by Application (2017-2022)

Table 13. Global Peptide Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Peptide Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Peptide Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Peptide Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Peptide Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Peptide Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Peptide Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Peptide Vaccine Producing Area Distribution and Sales Area

Table 21. Players Peptide Vaccine Products Offered

Table 22. Peptide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Peptide Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Peptide Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Peptide Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Peptide Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Peptide Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Peptide Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Peptide Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Peptide Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Peptide Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Peptide Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Peptide Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Peptide Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Peptide Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Peptide Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Peptide Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Peptide Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Peptide Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Peptide Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Peptide Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Peptide Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Peptide Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Peptide Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Peptide Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Peptide Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Peptide Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Peptide Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Peptide Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Peptide Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Peptide Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Peptide Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Peptide Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Peptide Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Peptide Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Peptide Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Peptide Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Peptide Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Peptide Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Peptide Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Peptide Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Peptide Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Peptide Vaccine

Table 66. Key Market Challenges & Risks of Peptide Vaccine

Table 67. Key Industry Trends of Peptide Vaccine

Table 68. Peptide Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Peptide Vaccine Distributors List

Table 71. Peptide Vaccine Customer List

Table 72. Global Peptide Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Peptide Vaccine Sales Market Forecast by Region

Table 74. Global Peptide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Peptide Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Peptide Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Peptide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Peptide Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Peptide Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Peptide Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Peptide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Peptide Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Peptide Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Peptide Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Peptide Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Peptide Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Peptide Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Peptide Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Peptide Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Peptide Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Peptide Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Anergis Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Anergis Peptide Vaccine Product Offered

Table 94. Anergis Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Anergis Main Business

Table 96. Anergis Latest Developments

Table 97. Antigen Express Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Antigen Express Peptide Vaccine Product Offered

Table 99. Antigen Express Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Antigen Express Main Business

Table 101. Antigen Express Latest Developments

Table 102. Apitope Technology Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Apitope Technology Peptide Vaccine Product Offered

Table 104. Apitope Technology Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Apitope Technology Main Business

Table 106. Apitope Technology Latest Developments

Table 107. Artificial Cell Technologies Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Artificial Cell Technologies Peptide Vaccine Product Offered

Table 109. Artificial Cell Technologies Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Artificial Cell Technologies Main Business

Table 111. Artificial Cell Technologies Latest Developments

Table 112. Benovus Bio Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Benovus Bio Peptide Vaccine Product Offered

Table 114. Benovus Bio Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Benovus Bio Main Business

Table 116. Benovus Bio Latest Developments

Table 117. Celgene Corporation Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Celgene Corporation Peptide Vaccine Product Offered

Table 119. Celgene Corporation Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Celgene Corporation Main Business

Table 121. Celgene Corporation Latest Developments

Table 122. Immatics biotechnologies Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Immatics biotechnologies Peptide Vaccine Product Offered

Table 124. Immatics biotechnologies Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Immatics biotechnologies Main Business

Table 126. Immatics biotechnologies Latest Developments

Table 127. Merck Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Merck Peptide Vaccine Product Offered

Table 129. Merck Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Merck Main Business

Table 131. Merck Latest Developments

Table 132. ImmunoCellular Therapeutics Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. ImmunoCellular Therapeutics Peptide Vaccine Product Offered

Table 134. ImmunoCellular Therapeutics Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. ImmunoCellular Therapeutics Main Business

Table 136. ImmunoCellular Therapeutics Latest Developments

Table 137. ISA Pharmaceuticals Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. ISA Pharmaceuticals Peptide Vaccine Product Offered

Table 139. ISA Pharmaceuticals Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. ISA Pharmaceuticals Main Business

Table 141. ISA Pharmaceuticals Latest Developments

Table 142. Lytix Biopharma Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. Lytix Biopharma Peptide Vaccine Product Offered

Table 144. Lytix Biopharma Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Lytix Biopharma Main Business

Table 146. Lytix Biopharma Latest Developments

Table 147. Spotlight Innovation Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 148. Spotlight Innovation Peptide Vaccine Product Offered

Table 149. Spotlight Innovation Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Spotlight Innovation Main Business

Table 151. Spotlight Innovation Latest Developments

Table 152. OncoTherapy Science Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 153. OncoTherapy Science Peptide Vaccine Product Offered

Table 154. OncoTherapy Science Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. OncoTherapy Science Main Business

Table 156. OncoTherapy Science Latest Developments

Table 157. Peptech Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 158. Peptech Peptide Vaccine Product Offered

Table 159. Peptech Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 160. Peptech Main Business

Table 161. Peptech Latest Developments

Table 162. Pharmasyntez Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 163. Pharmasyntez Peptide Vaccine Product Offered

Table 164. Pharmasyntez Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 165. Pharmasyntez Main Business

Table 166. Pharmasyntez Latest Developments

Table 167. Sumitomo Dainippon Pharma Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 168. Sumitomo Dainippon Pharma Peptide Vaccine Product Offered

Table 169. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 170. Sumitomo Dainippon Pharma Main Business

Table 171. Sumitomo Dainippon Pharma Latest Developments

Table 172. TapImmune Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 173. TapImmune Peptide Vaccine Product Offered

Table 174. TapImmune Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 175. TapImmune Main Business

Table 176. TapImmune Latest Developments

Table 177. Targovax Basic Information, Peptide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 178. Targovax Peptide Vaccine Product Offered

Table 179. Targovax Peptide Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 180. Targovax Main Business

Table 181. Targovax Latest Developments

List of Figures

Figure 1. Picture of Peptide Vaccine

Figure 2. Peptide Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Peptide Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Peptide Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Peptide Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Solution Phase Synthesis (SPS)

Figure 10. Product Picture of Solid Phase Peptide Synthesis (SPPS)

Figure 11. Global Peptide Vaccine Sales Market Share by Type in 2021

Figure 12. Global Peptide Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Peptide Vaccine Consumed in Prostate Cancer

Figure 14. Global Peptide Vaccine Market: Prostate Cancer (2017-2022) & (K Units)

Figure 15. Peptide Vaccine Consumed in Breast Cancer

Figure 16. Global Peptide Vaccine Market: Breast Cancer (2017-2022) & (K Units)

Figure 17. Peptide Vaccine Consumed in Gastric Cancer

Figure 18. Global Peptide Vaccine Market: Gastric Cancer (2017-2022) & (K Units)

Figure 19. Peptide Vaccine Consumed in Lung Cancer

Figure 20. Global Peptide Vaccine Market: Lung Cancer (2017-2022) & (K Units)

Figure 21. Peptide Vaccine Consumed in Pancreatic Cancer

Figure 22. Global Peptide Vaccine Market: Pancreatic Cancer (2017-2022) & (K Units)

Figure 23. Peptide Vaccine Consumed in Others

Figure 24. Global Peptide Vaccine Market: Others (2017-2022) & (K Units)

Figure 25. Global Peptide Vaccine Sales Market Share by Application (2017-2022)

Figure 26. Global Peptide Vaccine Revenue Market Share by Application in 2021

Figure 27. Peptide Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Peptide Vaccine Revenue Market Share by Company in 2021

Figure 29. Global Peptide Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Peptide Vaccine Revenue Market Share by Geographic Region in 2021

Figure 31. Global Peptide Vaccine Sales Market Share by Region (2017-2022)

Figure 32. Global Peptide Vaccine Revenue Market Share by Country/Region in 2021

Figure 33. Americas Peptide Vaccine Sales 2017-2022 (K Units)

Figure 34. Americas Peptide Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. APAC Peptide Vaccine Sales 2017-2022 (K Units)

Figure 36. APAC Peptide Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Europe Peptide Vaccine Sales 2017-2022 (K Units)

Figure 38. Europe Peptide Vaccine Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Peptide Vaccine Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Peptide Vaccine Revenue 2017-2022 ($ Millions)

Figure 41. Americas Peptide Vaccine Sales Market Share by Country in 2021

Figure 42. Americas Peptide Vaccine Revenue Market Share by Country in 2021

Figure 43. United States Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Peptide Vaccine Sales Market Share by Region in 2021

Figure 48. APAC Peptide Vaccine Revenue Market Share by Regions in 2021

Figure 49. China Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Peptide Vaccine Sales Market Share by Country in 2021

Figure 56. Europe Peptide Vaccine Revenue Market Share by Country in 2021

Figure 57. Germany Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Peptide Vaccine Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Peptide Vaccine Revenue Market Share by Country in 2021

Figure 64. Egypt Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Peptide Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Peptide Vaccine in 2021

Figure 70. Manufacturing Process Analysis of Peptide Vaccine

Figure 71. Industry Chain Structure of Peptide Vaccine

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles